BRITTANY WENINEGAR: Open Payments
NPI 1407384480 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,263 in 126 payments from 21 companies in 2025. Trend: 2023 $2,581 · 2024 $2,755 · 2025 $2,263
Food & beverage: $2,164Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $365 |
| Novartis Pharmaceuticals Corporation | 18 | $296 |
| Janssen Biotech, Inc. | 16 | $279 |
| Incyte Corporation | 13 | $182 |
| GENZYME CORPORATION | 5 | $178 |
| LEO Pharma Inc. | 11 | $158 |
| UCB, Inc. | 8 | $154 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $142 |
| Lilly USA, LLC | 4 | $91 |
| PFIZER INC. | 4 | $81 |
Products named: TREMFYA, COSENTYX, DUPIXENT, SKYRIZI, OPZELURA, RINVOQ, Bimzelx, ADBRY.
Industry payments across AL — which companies pay providers there.
